CINECA IRIS Institutional Research Information System

MENEGATTI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.041
EU - Europa 3.605
AS - Asia 1.740
SA - Sud America 189
AF - Africa 46
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 13
Totale 10.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.868
IT - Italia 1.145
CN - Cina 846
IE - Irlanda 347
SE - Svezia 295
DE - Germania 286
FR - Francia 272
GB - Regno Unito 216
UA - Ucraina 194
FI - Finlandia 190
ES - Italia 187
KR - Corea 159
SG - Singapore 158
JP - Giappone 131
IN - India 123
CA - Canada 104
PL - Polonia 95
AT - Austria 94
BR - Brasile 89
VN - Vietnam 81
MX - Messico 57
TW - Taiwan 55
NL - Olanda 42
AU - Australia 39
TR - Turchia 39
CO - Colombia 38
CH - Svizzera 35
RO - Romania 34
RU - Federazione Russa 32
HK - Hong Kong 28
SA - Arabia Saudita 27
BE - Belgio 26
AR - Argentina 22
TH - Thailandia 22
GR - Grecia 20
PT - Portogallo 20
SI - Slovenia 17
CL - Cile 15
EG - Egitto 12
EU - Europa 12
HU - Ungheria 12
IL - Israele 12
IR - Iran 11
PE - Perù 11
PH - Filippine 10
DK - Danimarca 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
HR - Croazia 7
NZ - Nuova Zelanda 7
RS - Serbia 7
ID - Indonesia 6
DZ - Algeria 5
KE - Kenya 5
MK - Macedonia 5
NO - Norvegia 5
SD - Sudan 5
UZ - Uzbekistan 5
VE - Venezuela 5
NI - Nicaragua 4
SN - Senegal 4
TN - Tunisia 4
UY - Uruguay 4
CU - Cuba 3
EC - Ecuador 3
IQ - Iraq 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
MY - Malesia 3
ZA - Sudafrica 3
AM - Armenia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
LB - Libano 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
QA - Qatar 1
Totale 10.680
Salva come PNG Salva come JPEG
Città #
Chandler 502
Beijing 422
Fairfield 389
Ann Arbor 383
Dublin 330
Torino 271
Houston 226
Wilmington 212
Ashburn 200
Woodbridge 199
Jacksonville 155
Seattle 145
Cambridge 135
Redwood City 127
Villeurbanne 126
Medford 121
Dearborn 113
Princeton 107
Nyköping 95
Milan 93
Turin 89
Singapore 86
Pisa 84
Warsaw 82
Vienna 78
Dong Ket 53
Shanghai 45
Boston 43
New York 39
Toronto 33
Nanjing 32
Sesto San Giovanni 32
Guangzhou 31
Helsinki 31
Rome 30
Tainan City 30
Hangzhou 29
Madrid 28
Tokyo 28
Boardman 26
Fremont 25
Los Angeles 25
Paris 24
San Diego 21
Verona 21
Hefei 19
Seoul 19
Chicago 18
Munich 18
Brussels 17
Córdoba 17
Taipei 17
London 16
Jinan 15
Norwalk 15
Ottawa 15
Riyadh 15
Silver Spring 15
Fuzhou 14
Hong Kong 14
Mexico City 14
Wuhan 14
Athens 13
Bucharest 13
Chengdu 13
Lachine 13
Kunming 12
Mumbai 12
Washington 12
Barcelona 11
Bengaluru 11
Valencia 11
Bangkok 10
Palermo 10
Phoenix 10
Dallas 9
Falls Church 9
Florence 9
Lima 9
Medellín 9
Padova 9
Pune 9
Rochester 9
Shenyang 9
Ankara 8
Bogotá 8
Burgess Hill 8
Frankfurt am Main 8
Kansas City 8
Santander 8
Serra 8
Sevilla 8
São Paulo 8
Tarragona 8
Zhengzhou 8
Berlin 7
Brescia 7
Düsseldorf 7
Nanchang 7
Tianjin 7
Totale 6.023
Salva come PNG Salva come JPEG
Nome #
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 504
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 493
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 459
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 444
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 365
Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. 325
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 324
Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw. 319
Upcoming biological therapies in systemic lupus erythematosus. 278
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 255
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 251
Spontaneous remission in a Diamond-Blackfan anaemia patient due to a revertant uniparental disomy ablating a de novo RPS19 mutation 244
Treatment of antiphospholipid syndrome 239
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 197
Rituximab in cryoglobulinemic peripheral neuropathy 195
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS 193
Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases. 184
Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws 177
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 171
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 168
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 166
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 160
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets 159
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 154
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 146
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 127
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome 123
4-idrossinonenale: un regolatore endogeno del potenziale replicativi delle cellule 120
Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study 118
OI0362 Functional analysis of interferon-γ and tumor necrosis factor α polymorphisms in lichen planus 110
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 103
Analisi genetica del gene CYP21 in forme non classiche di deficit di 21-beta-idrossilasi 101
5-Lipoxygenase gene expression in hemodialysis. 92
Absence of NF-kappaB activation by a new polystyrene-type adsorbent designed for hemoperfusion 92
BIOCOMPATIBILITY EVALUATION OF LOW FLUXS CELLULOSE TRIACETATE MEMBRANE 87
Somatic mosaicism and variable expressivity in Diamond Blackfan anemia (DBA): a gross deletion involving the 19q13 locus in a patient with transient anemia 84
Molecular genetic analysis of von Hippel-Lindau disease by denaturing high-performance liquid chromatography. 83
Immunological rare diseases 83
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 81
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines 80
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network, in colon cancer cells 80
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 79
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 77
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 72
Associazione tra polimorfismo del fattore di crescita trasformante e nefropatia IgA 69
4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity 68
Unusual association of pancreatic neuroendocrine tumors and papillary renal cell cancer. 68
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 68
A case of medullary thyroid carcinoma, parathyroid focal hyperplasia and pancreatic neuroendocrine tumor without RET and MEN1 mutations 67
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 66
Interleukin-6 production by endothelial cells: effect of corticosteroids. 64
Atypical presence of antimyeloperoxidase antibodies in 2 transplanted patients. 63
DNA methylation analysis in patients with bisphosphonate-related osteonecrosis of the jaws. 63
Immunogenetics of complement in mixed cryoglobulinaemia 63
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 63
Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy. 61
Effetti dei sieri ANCA-positivi sulla produzione granulocitaria di radicali dell'ossigeno molecolare 61
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 61
Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy 60
Genotype, phenotype and hormonal levels correlation in nonclassical congenital adrenal hyperplasia 57
Mechanisms of telomerase activity and hTERT expression inhibition by HNE in human leukemic cells 56
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 56
Correlation between genotype and hormonal levels in heterozygous mutation carriers and non carriers of 21-OH deficiency 55
Quantitative and genotypic analysis of the hepatitis C virus (HCV) detected in lymphocytes and monocytes from patients with cryoglobulinaemic glomerulonephrtitis. 54
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 54
L'espressione genica degli enzimi della catena lipossigenasica: un esempio del possibile ruolo dell'approccio biologico-molecore allo studio delle nefropatie glomerulari. 53
Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients 51
Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis. 50
Antineutrophil cytoplasm and antielastase antibodies in hemolytic-uremic syndrome. 50
Relationship between cryoglobulinemia-associated nephritis and HCV infection 50
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 49
Effects of ANCA-positive sera on the generation of oxygen free radicals by neutrophils. 45
Inhibition of Human alpha, beta and Thrombin by mono, bis, tris and tetrabenzamidine: strucural and thermodinamic study 45
Inhibition of Bovine ß-Trypsin, Human a-Thrombin and Porcine Pancreatic ß-Kallicrein-B by Benzamidine and its Bis-, Tris-and Tetra-Derivatives: Thermodynamic and Molecular Modeling study 44
Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort 43
Gene expression of 5-lipoxygenase and LTA4 hydrolase in renal tissue of nephrotic syndrome patients. 43
Studio dei riarrangiamenti del gene CYP21 in pazienti affetti dalla forma classica di sindrome adrenogenitale congenita: valutazione di un nuovo approccio analitico 43
Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis 42
Development of a miniaturized, automated assay for genetic testing 42
Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in haemodialysis. 41
PRELIMINARY ANALYSIS OF UTEROBLOBIN GENE POLYMORPHISM IN IgA NEPHROPATHY 41
Cytokine release pathway in mononuclear cells stimulated in vitro by dialysis membranes. 39
Mechanisms of the antiproliferative effects of mycophenolate mofetil on on glomerular cells 39
Risultati preliminari di uno studio sull'espressione di RNAm per enzimi del metabolismo dell'acido arachidonico in sindromi mefrosiche 39
CD36 IS ONE OF THE IMMUNOLOGICAL MARKERS EXPRESSED BY KERATINOCYTES IN ACTIVE HYPERTROPHIC SCARS 38
Modulazione farmacologica dell'espressione delle proteine della regolazione del ciclo cellulare in un modello sperimentale di nefrite mesangiale 38
Intradialytic cytokine gene expression. 38
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 35
HCV infection: pathogenesis, clinical manifestations and therapy 35
Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27kip1 expression in animal model of proliferative glomerulonephritis. 32
Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis. 31
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 28
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 28
Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study 27
Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4'-6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine 26
Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease 25
N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin. 24
Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants 23
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 23
Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms 22
Totale 10.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.159
article - articoli 0
book - libri 0
conference - conferenze 3.850
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.509 0 86 100 158 94 191 195 139 168 150 129 99
2020/20211.372 106 93 155 131 114 85 91 85 131 142 96 143
2021/20221.471 79 73 130 124 107 125 122 109 80 68 203 251
2022/20231.873 189 130 64 154 169 418 155 138 195 63 103 95
2023/20241.355 161 186 82 90 142 116 98 89 23 91 114 163
2024/202569 61 8 0 0 0 0 0 0 0 0 0 0
Totale 11.076